Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)

Lindsay M. Morton, Jennifer J. Turner, James R Cerhan, Martha S. Linet, Patrick A. Treseler, Christina A. Clarke, Andrew Jack, Wendy Cozen, Marc Maynadié, John J. Spinelli, Adele Seniori Costantini, Thomas Rüdiger, Aldo Scarpa, Tongzhang Zheng, Dennis D. Weisenburger

Research output: Contribution to journalArticle

290 Citations (Scopus)

Abstract

Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases-Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.

Original languageEnglish (US)
Pages (from-to)695-708
Number of pages14
JournalBlood
Volume110
Issue number2
DOIs
StatePublished - Jul 15 2007

Fingerprint

Epidemiology
Pathology
Lymphoma
Research
Neoplasms
Lymphoid Leukemia
International Classification of Diseases
Oncology
Sample Size
Meta-Analysis
Epidemiologic Studies
Standardization
Health

ASJC Scopus subject areas

  • Hematology

Cite this

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). / Morton, Lindsay M.; Turner, Jennifer J.; Cerhan, James R; Linet, Martha S.; Treseler, Patrick A.; Clarke, Christina A.; Jack, Andrew; Cozen, Wendy; Maynadié, Marc; Spinelli, John J.; Costantini, Adele Seniori; Rüdiger, Thomas; Scarpa, Aldo; Zheng, Tongzhang; Weisenburger, Dennis D.

In: Blood, Vol. 110, No. 2, 15.07.2007, p. 695-708.

Research output: Contribution to journalArticle

Morton, LM, Turner, JJ, Cerhan, JR, Linet, MS, Treseler, PA, Clarke, CA, Jack, A, Cozen, W, Maynadié, M, Spinelli, JJ, Costantini, AS, Rüdiger, T, Scarpa, A, Zheng, T & Weisenburger, DD 2007, 'Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)', Blood, vol. 110, no. 2, pp. 695-708. https://doi.org/10.1182/blood-2006-11-051672
Morton, Lindsay M. ; Turner, Jennifer J. ; Cerhan, James R ; Linet, Martha S. ; Treseler, Patrick A. ; Clarke, Christina A. ; Jack, Andrew ; Cozen, Wendy ; Maynadié, Marc ; Spinelli, John J. ; Costantini, Adele Seniori ; Rüdiger, Thomas ; Scarpa, Aldo ; Zheng, Tongzhang ; Weisenburger, Dennis D. / Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). In: Blood. 2007 ; Vol. 110, No. 2. pp. 695-708.
@article{a475f9dee6d84af988097664182599db,
title = "Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)",
abstract = "Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases-Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.",
author = "Morton, {Lindsay M.} and Turner, {Jennifer J.} and Cerhan, {James R} and Linet, {Martha S.} and Treseler, {Patrick A.} and Clarke, {Christina A.} and Andrew Jack and Wendy Cozen and Marc Maynadi{\'e} and Spinelli, {John J.} and Costantini, {Adele Seniori} and Thomas R{\"u}diger and Aldo Scarpa and Tongzhang Zheng and Weisenburger, {Dennis D.}",
year = "2007",
month = "7",
day = "15",
doi = "10.1182/blood-2006-11-051672",
language = "English (US)",
volume = "110",
pages = "695--708",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)

AU - Morton, Lindsay M.

AU - Turner, Jennifer J.

AU - Cerhan, James R

AU - Linet, Martha S.

AU - Treseler, Patrick A.

AU - Clarke, Christina A.

AU - Jack, Andrew

AU - Cozen, Wendy

AU - Maynadié, Marc

AU - Spinelli, John J.

AU - Costantini, Adele Seniori

AU - Rüdiger, Thomas

AU - Scarpa, Aldo

AU - Zheng, Tongzhang

AU - Weisenburger, Dennis D.

PY - 2007/7/15

Y1 - 2007/7/15

N2 - Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases-Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.

AB - Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases-Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.

UR - http://www.scopus.com/inward/record.url?scp=34547130845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547130845&partnerID=8YFLogxK

U2 - 10.1182/blood-2006-11-051672

DO - 10.1182/blood-2006-11-051672

M3 - Article

C2 - 17389762

AN - SCOPUS:34547130845

VL - 110

SP - 695

EP - 708

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -